Publications
183
Citations
8,518
Est. group size
—
Recurring co-author estimate
Active years
38
Publishing since 1988
This researcher studies the genetics and cellular biology of pulmonary arterial hypertension (PAH), a disease of high blood pressure in the vessels of the lungs. Their work identifies gene variants (such as in BMPR2, FOXF1, and TBX4) linked to the disease, develops guidelines for classifying which variants are harmful, and uses single-cell technologies to map how different lung cell types behave in the disease. They also examine related conditions like hereditary hemorrhagic telangiectasia and scleroderma-associated PAH.
Publication activity has grown over the past decade, rising notably from around 2020 onward with a peak of 16 papers in 2023 and sustained high output since.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial Hypertension
Circulation Genomic and Precision Medicine · 2025
- When “loss-of-function” means proteostasis burden: Thinking again about coding DNA variants
The American Journal of Human Genetics · 2025
- Association of FOXF1 Genomic Variants With Children and Adults With Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine · 2025
- Investigating Somatic Mutations in Pulmonary Lesions of Patients With Hereditary Pulmonary Arterial Hypertension and Hereditary Hemorrhagic Telangiectasia
American Journal of Respiratory and Critical Care Medicine · 2025
- Pulmonary Arterial Hypertension Single-cell Atlas of the Human Lung
American Journal of Respiratory and Critical Care Medicine · 2025
- Abstract 4363044: A single-cell atlas of the human PAH lung identifies ITGA9 as a candidate regulator of fibroblast activation and vascular remodeling
Circulation · 2025
- Adaptation of ACMG/AMP Guidelines for Clinical Classification of <i>BMPR2</i> Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar
Human Mutation · 2025
- Genetics and precision genomics approaches to pulmonary hypertension
European Respiratory Journal · 2024
- Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT
Blood · 2024
- Dysregulation of the Long Noncoding RNA X-Inactive–Specific Transcript Expression in Male Patients with Pulmonary Arterial Hypertension
American Journal Of Pathology · 2024
- Alterations in Mitochondrial Function in Pulmonary Vascular Diseases
Antioxidants and Redox Signaling · 2024
- Role of Forkhead box F1 in the Pathobiology of Pulmonary Arterial Hypertension
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Single-cell transcriptomics reveal diverging pathobiology and opportunities for precision targeting in scleroderma-associated versus idiopathic pulmonary arterial hypertension
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- TBX4 Loss-of-function Within the Developing Lung Disrupts Postnatal Lung Development and Predisposes to Pulmonary Hypertension
2024
- Increased Bone Morphogenetic Protein–Responsive Transcription Factors in Distinct Endothelial and Mesenchymal Cells in Pulmonary Artery Hypertension
American Journal of Respiratory and Critical Care Medicine · 2024
- Circulation×8
- bioRxiv (Cold Spring Harbor Laboratory)×7
- American Journal of Respiratory and Critical Care Medicine×6
- The American Journal of Human Genetics×3
- European Heart Journal - Cardiovascular Imaging×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile